ORBIMED ADVISORS LLC 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-15 4:47 pm Purchase | 2024-08-13 | 13D | SCPHARMACEUTICALS INC SCPH | ORBIMED ADVISORS LLC | 6,059,528 12.100% | 500,000 (+8.99%) | Filing |
| 2022-11-29 4:27 pm Purchase | 2022-11-25 | 13D | SCPHARMACEUTICALS INC SCPH | ORBIMED ADVISORS LLC | 5,559,528 16.300% | 762,380 (+15.89%) | Filing |